StockData
Mesabi Trust logo

Mesabi Trust (MSB) stock analysis

MSBNYSEMineral Royalty TradersFiscal year ends January 31
Financials through Q2 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 11, 2026Score 8/302% above fair value
$17.22+0.03 (+0.17%)

Close on Nov 11, 2026Market cap $225.93MP/E 35.1Yield –

StockData Score

Prices as of Nov 11, 2026How the score works

Value0Growth1Performance1Health5Dividend1

Weak8 of 30 checks passed

Mesabi Trust passes 8 of the 30 checks behind our score; 9 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
0/6
Growth
1/6
Past performance
1/6
Financial health
5/6
Dividend
1/6

What stands out

  • No debt

    Mesabi Trust has no borrowings on its latest balance sheet.

  • Revenue growing 10%+ a year

    Revenue grew 31.3% a year over the last three fiscal years.

  • Interest well covered

    No meaningful interest expense to cover.

  • Debt covered by cash flow

    There is no debt to cover.

What to watch

  • Margin of safety under 20%

    The price is 1.8% above fair value, so there is no margin of safety.

  • Trading above fair value

    The share price of $17.22 is above our fair value estimate of $16.92.

  • Earnings shrank over 5 years

    Net income shrank 9.9% a year on average over the last five fiscal years.

  • Earnings growth not accelerating

    Net income grew -93.0% over the last twelve months, against a 5-year average of -9.9% a year.

Valuation0/6
  • P/E above its 5-year median

    Mesabi Trust's P/E of 35.1 is above its own 5-year median of 10.6.

  • P/E above the industry

    Mesabi Trust's P/E of 35.1 is above the Miscellaneous Investing median of 26.3.

  • EV/EBITDA against its history

    Needs positive EBITDA and price history.

  • P/S above the industry

    Mesabi Trust's price-to-sales of 18.97 is above the Miscellaneous Investing median of 4.14 (book value is negative, so we use sales).

  • Trading above fair value

    The share price of $17.22 is above our fair value estimate of $16.92.

  • Margin of safety under 20%

    The price is 1.8% above fair value, so there is no margin of safety.

Growth1/6
  • Revenue growing 10%+ a year

    Revenue grew 31.3% a year over the last three fiscal years.

  • EPS growth over 3 years

    Needs positive EPS three years ago and today.

  • Earnings growth not accelerating

    Net income grew -93.0% over the last twelve months, against a 5-year average of -9.9% a year.

  • Growing slower than the industry

    Revenue grew -87.6% over the last twelve months; the Miscellaneous Investing median is 4.6%.

  • Company guidance

    No outlook found in earnings releases from the last twelve months.

  • Gross margin slipping

    Gross margin was 54.5% over the last twelve months, against 96.4% a year earlier.

Past performance1/6
  • Return on equity

    Needs positive equity and five years of results.

  • Return on invested capital

    Needs operating income and invested capital.

  • Return on equity against the industry

    Needs positive equity.

  • Earnings shrank over 5 years

    Net income shrank 9.9% a year on average over the last five fiscal years.

  • Net margin below its 5-year average

    Net margin was 54.5% over the last twelve months, against a 5-year average of 84.3%.

  • Net margin above the industry

    Mesabi Trust's net margin of 54.5% is above the Miscellaneous Investing median of 10.3%.

Financial health5/6
  • No debt

    Mesabi Trust has no borrowings on its latest balance sheet.

  • Debt not rising

    With no debt today, leverage cannot have risen.

  • Debt covered by cash flow

    There is no debt to cover.

  • Interest well covered

    No meaningful interest expense to cover.

  • Short-term liquidity

    The balance sheet is not split into current and non-current items.

  • Low bankruptcy risk

    The Altman Z-score is 60.78; above 3 is the safe zone and below 1.8 the distress zone.

Dividend1/6
  • Pays a dividend

    Mesabi Trust paid dividends worth 3.2% of the share price over the last twelve months.

  • Yield below Treasuries

    The 3.2% yield is below the 4.4% on a 1-year Treasury.

  • Yield below the top quarter

    The top quarter of US dividend payers yield 3.8% or more; Mesabi Trust yields 3.2%.

  • Dividend stability

    Fewer than five years of dividend history.

  • Not covered by earnings

    Dividends take 194% of net income, leaving little room.

  • Cash-flow cover

    Needs dividends paid and free cash flow.

Scores of similar companies

Our estimate per share

$16.92

The share price is 2% above this estimate.

20%+ below
Near fair value
20%+ above
$17.22Price
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E18.8×10.6×26.3×$9.2273%
Earnings power8.3% cost of equity––$37.4527%
Fair value$16.92100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 10.6
  • Miscellaneous Investing median 26.3

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

High risk

Average value traded per day
$868.15K
Value traded per 1% price move
$367.23K

Downside

Medium risk

Typical loss in a bad month
19.9%
Volatility (annualized)
45%
Sharpe ratio, 1 year
-1.21
Beta to the S&P 500 (5Y)
0.69

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Gross margin

79.1%−11.1 pts over 5 years

Net margin

79.1%−11.1 pts over 5 years

See a number that looks wrong?